Due to abolished Fcγ receptor binding (P329G LALA mutations), FAP-IL-2v does not induce ADCC against FAP-positive cells and serves as a vehicle for IL-2v, transporting it into the tumor microenvironment. The gene discussed is FAP; the disease is neoplasm.